miR-122 was reported to play a pivotal role as tumor suppressor by decreasing AKT3 levels, inhibiting cell migration and proliferation and inducing apoptosis [66], whereas miR-184 was found to be involved in suppressing cell survival and growth by targeting AKT2 in neuroblastoma cells [67]. The gene discussed is AKT2; the disease is neuroblastoma.